Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCK | P35557 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 12/20 | 0.40 |
| ▸ | CNR1 | P21554 | 5/20 | 0.39 |
| ▸ | BRAF | P15056 | 1/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4009700 | 0.94 | CNR2 (0.39) | GCKCNR2CNR1BRAFNPY5R | |
| SCHEMBL1620968 | 0.85 | NPY5R (0.48) | GCKCNR2CNR1NPY5RNPC1 | |
| SCHEMBL1621095 | 0.84 | NPY5R (0.47) | GCKCNR2CNR1NPY5RNPC1 | |
| SCHEMBL4016742 | 0.83 | NPC1 (0.42) | CNR2CNR1NPC1 | |
| SCHEMBL1620231 | 0.83 | CNR2 (0.50) | CNR2CNR1BRAF | |
| SCHEMBL1621563 | 0.82 | CNR2 (0.49) | CNR2CNR1BRAF | |
| SCHEMBL4015488 | 0.82 | NPC1 (0.44) | CNR2CNR1NPC1 | |
| SCHEMBL1621338 | 0.81 | NPY5R (0.51) | GCKCNR2CNR1NPY5RNPC1 | |
| SCHEMBL4010277 | 0.80 | CNR2 (0.34) | GCKCNR2CNR1 | |
| SCHEMBL1621075 | 0.80 | CNR2 (0.54) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2074084-A1 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | Boehringer Ingelheim International GmbH (DE) | 2009-07-01 | — | — | EP | claimed |
| WO-2008039645-A1 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-04-03 | — | — | WO | claimed |